Market Cap | 9.88M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -289.82k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -20.00% |
Sales | 1.61M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -25.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -60.00% |
Recommedations | - | Quick Ratio | 0.01 | Shares Outstanding | 24.71B | 52W Low Chg | 33.00% |
Insider Own | - | ROA | -33.67% | Shares Float | - | Beta | 0.92 |
Inst Own | 0.00% | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00040 |
Gross Margin | 49.43% | Profit Margin | -18.01% | Avg. Volume | 11,969,367 | Target Price | - |
Oper. Margin | -22.19% | Earnings Date | Jul 10 | Volume | 12,923,340 | Change | -20.00% |
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.